Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Jun 26, 2013; 5(6): 196-206
Published online Jun 26, 2013. doi: 10.4330/wjc.v5.i6.196
Published online Jun 26, 2013. doi: 10.4330/wjc.v5.i6.196
Category | Low risk | Intermediate risk | High risk | Gamma for trend | P value | |
Clinically significant bleeding events | ||||||
Derivation cohort (follow-up: 19.9 ± 6.7 mo) | Incidence | 0.80% | 3.40% | 14.40% | 0.70 ± 0.08 | < 0.001 |
Validation cohort (follow-up: 13.4 ± 8.1 mo) | Incidence | 1.30% | 5.00% | 14.10% | 0.61 ± 0.08 | < 0.001 |
Composite endpoint (bleeding + all-cause mortality) | ||||||
Derivation cohort (follow-up: 19.9 ± 6.7 mo) | Incidence | 3.10% | 11.40% | 45.70% | 0.76 ± 0.04 | < 0.001 |
Validation cohort (follow-up: 13.4 ± 8.1 mo) | Incidence | 1.30% | 9.30% | 31.30% | 0.73 ± 0.05 | < 0.001 |
- Citation: Barra S, Providência R, Caetano F, Almeida I, Paiva L, Dinis P, Leitão Marques A. BLEED-Myocardial Infarction Score: Predicting mid-term post-discharge bleeding events. World J Cardiol 2013; 5(6): 196-206
- URL: https://www.wjgnet.com/1949-8462/full/v5/i6/196.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i6.196